Replies to post #7001 on Repros Therapeutics, Inc. (RPRX)

[jmkobers]

To me this is a clear signal that things remain on track at this time.

The trials to date have shown great efficacy so let's assume that it would be unlikely to encounter issues here. If a major safety issue recently came to light, one serious enough to put the program in jeopardy, what good would it do to assemble a panel of experts?

Absolutely none.

[zipjet]

Charmed,

I for one want to see hptaxis proven wrong. He does have a bias - don't we all. :-)

That last post of his is a good example of critical reading. Reading not to see the obvious point being made but rather to see what is being obfuscated. One thing that I am sure of is that we need to read PR's critically for what is being avoided not just the obvious point being made.

ij